EcoDrugPlus

Tachykinin Receptor 3

Ensembl ID : ENSJJAG00000023236
Gene Symbol: TACR3
3 Cross references
256 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSJJAG00000015110
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSJJAG00000020954
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSJJAG00000015378
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSJJAG00000013852
Gene Symbol: TYMP
3 Cross references
173 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSJJAG00000020713
Gene Symbol: TYMS
3 Cross references
223 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSJJAG00000006766
Gene Symbol: THRB
3 Cross references
392 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSJJAG00000020928
Gene Symbol: TRHR
3 Cross references
266 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSJJAG00000021076
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSJJAG00000003676
Gene Symbol: TLR8
3 Cross references
200 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSJJAG00000016253
Gene Symbol: TLR9
3 Cross references
82 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSJJAG00000008037
Gene Symbol: TGFBR1
3 Cross references
230 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).